Drugs / Marketed rabies vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07357545 Comparator | Aug 2021 → Sep 2022 | — | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Marketed rabies vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07357545 ↗ |
| Modality | Vaccine | “A markted Rabies Vaccine using 5 doses of PEP schedules” NCT07357545 ↗ |